Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00577785
NCT00577785
Completed
Not Applicable

A Multi-Center Study to Obtain Full Thickness Bladder Tissue Specimen From Subjects Undergoing Cystectomy Surgery

Tengion1 site in 1 country52 target enrollmentAugust 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCystectomy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cystectomy
Sponsor
Tengion
Enrollment
52
Locations
1
Primary Endpoint
Evaluation of bladder tissue from patients underogoing radical cystectomy
Status
Completed
Last Updated
15 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The objective of this study is to obtain bladder tissue specimens from patients otherwise undergoing cystectomy for use in research and training of personnel at Tengion, Inc.

Registry
clinicaltrials.gov
Start Date
August 2007
End Date
January 2009
Last Updated
15 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Tengion

Eligibility Criteria

Inclusion Criteria

  • •Subjects 18 to 90 years and undergoing a cystectomy surgery
  • •Willing and able to give signed informed consent

Exclusion Criteria

  • •Known active infection
  • •Known colonization with MRSA or VRE
  • •Receipt of blood or blood products for transfusion during the previous 3 months

Outcomes

Primary Outcomes

Evaluation of bladder tissue from patients underogoing radical cystectomy

Time Frame: ongoing throughout study

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Multi Center Study to Obtain Bladder Tissue Specimens From Patients Undergoing Transurethral Resection Biopsy ProcedureBladder Disease
NCT00615043Tengion6
Completed
Phase 1
Augmenting Flortaucipir Dosimetry EstimatesAlzheimer's Disease
NCT02336360Avid Radiopharmaceuticals6
Recruiting
Not Applicable
A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of CancerBarrett's EsophagusEsophageal Adenocarcinoma
NCT06523374University Hospital, Antwerp50
Terminated
Not Applicable
Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer.Breast Cancer
NCT06126003BioCorteX Inc2
Recruiting
Not Applicable
Precision Genomics Medicine BiobankAny Disease Condition and Reportedly-healthy Subjects
NCT04187729Intermountain Health Care, Inc.100,000